---
title: "IKSUDA THERAPEUTICS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/284c5160-d27c-571f-b23d-ecea6ff2c7d4
json: https://whiteintel.dev/api/public/dossier/284c5160-d27c-571f-b23d-ecea6ff2c7d4
identifier: oo:GB-COH-06433234
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# IKSUDA THERAPEUTICS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-06433234`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/284c5160-d27c-571f-b23d-ecea6ff2c7d4  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/284c5160-d27c-571f-b23d-ecea6ff2c7d4  

## Ownership & control

### Owners / controllers

- **Ip2ipo Limited** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/70c1d5f4-faba-4ade-831b-0aaa9ac4a360
- **North East Technology (Gp) Limited** (beneficial owner) — https://whiteintel.dev/entity/617aa48c-1c04-4f96-bcd8-d8aeca5f275d

### Holdings / subsidiaries

- **GLYTHERA LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/84fe13c2-1817-5880-b804-8a910c11b74d
- **GLYTHERA LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/84fe13c2-1817-5880-b804-8a910c11b74d

### UBO chain (walk to the ultimate owner)

A **2-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `06433234`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2007-11-21
- **Registered office:** The Biosphere Draymans Way, Newcastle Helix, Newcastle Upon Tyne, NE4 5BX, United Kingdom
- **SIC:** 72110

### Officers

- KIM, Yong Zu — director · South Korean · appointed 2025-03-14
- PARK, Se Jin — director · South Korean · appointed 2025-03-14
- PONTE, Jose, Dr — director · American · appointed 2024-10-28
- SIMPSON, David John, Dr — director · British · appointed 2014-03-28
- [IP2IPO SERVICES LIMITED](https://whiteintel.dev/entity/b21b9a75-76e8-5cdc-9da2-2bf770496dd4) — corporate director · appointed 2008-09-04
- ADERYN, Diane — secretary · British · appointed 2007-11-21 · resigned 2008-09-04
- [IP2IPO SERVICES LIMITED](https://whiteintel.dev/entity/b21b9a75-76e8-5cdc-9da2-2bf770496dd4) — corporate secretary · appointed 2008-09-04 · resigned 2018-01-01
- BAINS, William Arthur, Dr — director · British · appointed 2008-11-28 · resigned 2014-04-25
- BAXTER, Anthony David, Dr — director · British · appointed 2008-10-03 · resigned 2015-04-24
- BLAIR, William Taninhill — director · British · appointed 2020-07-15 · resigned 2021-06-01
- BURNS, Nigel Robert, Dr — director · British · appointed 2014-02-28 · resigned 2016-04-18
- CHAE, Jeiwook — director · South Korean · appointed 2024-10-28 · resigned 2025-03-14
- JANG, Seungdeok — director · South Korean · appointed 2024-10-28 · resigned 2025-03-14
- JEONG, Seung Wook — director · South Korean · appointed 2021-06-01 · resigned 2024-01-05
- KWON, Bong Jin — director · South Korean · appointed 2024-01-05 · resigned 2024-10-28
- LUNT, George Gordon, Professor — director · British · appointed 2007-11-21 · resigned 2008-09-04
- MACKENZIE, Amanda, Dr — director · British · appointed 2008-09-04 · resigned 2010-12-13
- MACKENZIE LAMB, Alan Peter — director · British · appointed 2014-04-25 · resigned 2021-06-01
- OWEN, Michael John — director · British · appointed 2023-02-01 · resigned 2024-09-04
- OWEN, Michael John, Dr — director · British · appointed 2017-07-01 · resigned 2021-06-01

### Beneficial owners (Persons with Significant Control)

- Ip2ipo Limited — 25–50% shares · corporate PSC · United Kingdom — ceased 2021-06-01
- North East Technology (Gp) Limited — significant influence or control · corporate PSC · United Kingdom — ceased 2021-06-01

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/06433234
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/06433234

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **IKSUDA THERAPEUTICS LIMITED**. Human view: https://whiteintel.dev/entity/284c5160-d27c-571f-b23d-ecea6ff2c7d4 · Structured JSON: https://whiteintel.dev/api/public/dossier/284c5160-d27c-571f-b23d-ecea6ff2c7d4._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._